Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Assessing the Curative Effect of the Combination of Lobectomy Followed by Mediastinal Concomitant Radiochemotherapy in Patients With Locally Advanced Unresectable Stage III Non-small Cell Lung Cancer Responding to Induction Chemotherapy

NCT00661011 is registered in ClinicalTrials.gov with European Lung Cancer Working Party as lead sponsor.

NCT NCT00661011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00661011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Assessing the Curative Effect of the Combination of Lobectomy Followed by Mediastinal Concomitant Radiochemotherapy in Patients With Locally Advanced Unresectable Stage III Non-small Cell Lung Cancer Responding to Induction Chemotherapy
Lead sponsor
European Lung Cancer Working Party
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2007
Completion date
June 30, 2014
Enrollment
75 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung carcinoma